Ovid Therapeutics Inc. vs. Marinus Pharmaceuticals, Inc.

Explore the PTAB proceeding IPR2024-00726 filed by Ovid Therapeutics Inc. on 2024-03-26. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2024-00726

Filing Date

2024-03-26

Accorded Filing Date

2024-03-26

Institution Decision Date

2024-09-20

Last Modified Date

2024-10-22

Proceeding Type

IPR

Termination Date

2024-09-20

Trial Status

Institution Denied

Parties & Counsel

Petitioner

Ovid Therapeutics Inc.

Represented By

Tridico, Anthonyet al

Patent Owner / Respondent

Marinus Pharmaceuticals, Inc.

Represented By

Kane, Michaelet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 17186569

Respondent Patent Number 11110100

External Links

Espacenet

Google Patents

Respondent Inventor David CZEKAI et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

18 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name HOGAN LOVELLS US LLP - IP GROUP, COLUMBIA SQUARE

Customer Number 24633

Address 555 THIRTEENTH STREET, N.W., WASHINGTON, DC, 20004, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
40357	Celine Crowson	202-637-5600
45170	Robert Underwood	617-371-1019
46089	Melissa Schwaller	713-632-1449
48163	Jason Lohr	415-374-2300
57025	Kristin Connarn	617-535-4000
63523	Matthew Gibson	214-258-4103
65250	Helen Trac	248-495-0021
66218	Joseph Raffetto	+1 970 778 4063
68021	Hain-Whei Hsueh	415-273-7548
68385	Scott Hughes	202-637-3659
70017	Corey Leggett	303-899-7300
71636	Polly Sims	713-632-1400
72224	Joe Grdinovac	713-632-1400
75959	Nicholas Rotz	202-637-7807
76615	Rhianna Lindop	617-702-7741
78533	Connor Day	713-632-1418
79488	Lachlan Blair	617-702-7796
81768	Daniel Schultz	859-912-5813

Proceeding Documents

Notice: refund approved NOTICE

2024-10-09 FILING PARTY: BOARD

Download

Petitioner's Request for Refund of Post-Institution Fees OTHER

2024-10-03 FILING PARTY: PETITIONER

Download

Denying Institution of Inter Partes Review 35 U.S.C. § 314 DECISION

2024-09-20 FILING PARTY: BOARD

Download

2004

Marinus Press Release Dated October 17, 2019 Exhibit

2024-06-26 FILING PARTY: PATENT OWNER

Download

2031

Tsai et al., Phase I Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults Exhibit

2024-06-26 FILING PARTY: PATENT OWNER

Download

Ovid Therapeutics Inc. vs. Marinus Pharmaceuticals, Inc.

Proceeding Overview

Parties & Counsel

Petitioner

Ovid Therapeutics Inc.

Represented By

Patent Owner / Respondent

Marinus Pharmaceuticals, Inc.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Notice: refund approved NOTICE

Petitioner's Request for Refund of Post-Institution Fees OTHER

Denying Institution of Inter Partes Review 35 U.S.C. § 314 DECISION

Marinus Press Release Dated October 17, 2019 Exhibit

Tsai et al., Phase I Study to Determine the Pharmacokinetics, Pharmacodynamics, and Safety of IV Ganaxolone in Healthy Adults Exhibit

Declaration of Dr. Maciej Gasior Exhibit

WO 2018/031748A1 During PCT Exhibit

Supplemental Response filed May 11, 2022 Exhibit

Supplemental Information to Vaitkevicius et al., Intravenous Ganaxolone for the Treatment of Refractory Status Epilepticus Exhibit

Wylie et al., Status Epilepticus. Updated 2022 May 15 Exhibit

Imtiyaz et al., The Evolution of the Pilocarpine Animal Model of Status Epilepticus Exhibit

Transcript of Deposition of Dr. Raman Sankar, February 9, 2024 Exhibit

American Academy of Neurology (“AAN”) 2016 Annual Meeting Scientific Abstract Exhibit

Declaration of Dr. Henrikas Vaitkevicius Exhibit

https://ovidrx.com/our-company/leadership/, accessed June 20, 2024 Exhibit

Press Release Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone IV to Treat Status Epilepticus Exhibit

Trinka et al., A definition and classification of status epilepticus Exhibit

American Clinical Neurophysiology Society 2020 Annual Meeting Exhibit

Declaration of Anne Koch Baland with Attachments Exhibit

Petition for Post Grant Review of U.S. Patent No. 11,395,817 Exhibit

Seinfeld et al., Status Epilepticus Exhibit

WO 2016/127170A1 Zhang Exhibit

WIPO Publication No. WO 2007/062266 Shaw Exhibit

Declaration of Raman Sankar, M.D Exhibit

U.S. Provisional Patent Application 62/882,648 Exhibit

Reddy and Kuruba, Experimental Models of Status Epilepticus and Neuronal Injury for Evaluation of Therapeutic Interventions Exhibit

U.S. Application No. 2016/0228454 Zhang US Exhibit

Marinus Press Release dated December 7, 2019 Exhibit

Saporito et al., Intravenous Administration of Ganaxolone Attenuates Electroencephalographic Seizures in a Diazepam Resistant Model of Status Epilepticus Exhibit

Patent Owner's Preliminary Response POPR

Declaration of Dr. Michael A. Rogawski Exhibit

Abstracts for the 17th Annual Meeting, Neurocritical Care Society Exhibit

Press Release Marinus Pharmaceuticals Doses First Subject in Phase I Clinical Trial for Ganaxolone IV Exhibit

Saporito et al., Ganaxolone Administered Intravenously Prevents Behavioral Seizures and Promotes Survival in the Rat Lithium-Pilocarpine Model of Status Epilepticus Exhibit

Marinus Press Release dated February 3, 2020 Exhibit

Notice: Notice filing date accorded NOTICE

Patent Owner's Power of Attorney NOTICE

Patent Owner's Mandatory Notice NOTICE

Ozdemir 2005 Exhibit

Annals of Neurology Screenshot Exhibit

Monaghan 1997 Exhibit

Excerpts from File History of App. No. 15/673,737 Exhibit

During Exhibit

May 18, 2015 Marinus Press Release Exhibit

2016 Phase 1 Poster Exhibit

Ramsay 2019 Exhibit

Sankar 2023 Exhibit

'100 patent FH_excerpted Exhibit

Shaw Exhibit

Shorvon 2001 Exhibit

Tsai 2016 Exhibit

Vaitkevicius 2017 Exhibit

Trinka Exhibit

Practical Neurology 2019 Exhibit

NCT03350035 Clinical Trial Exhibit

Currie 2018 Exhibit

WO '124 A1 Exhibit

Tsai 2017 Exhibit

Vaitkevicius 2022 Exhibit

Zolkowska 2018 Exhibit

Sankar Declaration Exhibit

Carter 1997 Exhibit

Sperling 2017 Exhibit

AES Poster 2019 Exhibit

Petition for an Inter Partes Review of U.S. Patent No. 11,110,100 PETITION